Dolsten Mikael
SEC CIK 1437590 · EDGAR
BoughtSold
Most active insiders at A, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MCDONNELL PADRAIG | Pres, CEO, Dir | — | $2.00M |
| 2 | Dolsten Mikael | Dir | — | $702.1K |
| 3 | Gonsalves Rodney | VP, Corp. Ctrl | — | $465.0K |
| 4 | Buckner Michael Steven | SVP | — | — |
| 5 | Elinoff Adam Stewart | SVP, CFO | — | — |
| 6 | KIRKWOOD JONAH PREVOST | SVP | — | — |
| 7 | ZHANG JIANMIAO MIKE | SVP | — | — |
| 8 | RIEMANN ANGELICA | SVP | — | — |
| 9 | MAY SIMON | SVP | — | — |
| 10 | Henson Meghan | SVP | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 16:01 | 2026-09-04 | A | Agilent Technologies | Dolsten Mikael | Dir | S - Sale | $151.38 | -634 | 4,924 | -11% | -$96.0K | |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Dolsten Mikael | Dir | A - Grant | $0.00 | +22.9K | 67.1K | +52% | $0 |
| 2026-06-02 16:01 | 2026-05-29 | A | Agilent Technologies | Dolsten Mikael | Dir | S - Sale | $135.42 | -1,600 | 5,548 | -22% | -$216.7K | |
| 2026-03-23 | 2026-03-19 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $111.75 | +2,158 | 7,138 | +43% | +$241.2K | |
| 2025-12-03 | 2025-12-01 | A | Agilent Technologies | Dolsten Mikael | Dir | S - Sale | $149.81 | -2,600 | 4,973 | -34% | -$389.5K | |
| 2025-07-18 | 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Dolsten Mikael | Dir | A - Grant | $0.00 | +30.0K | 44.2K | +211% | $0 | |
| 2025-04-24 | 2025-03-05 | RCKT | ROCKET PHARMACEUTICALS, INC. | Dolsten Mikael | Dir | J - Other | $0.00 | +14.2K | 14.2K | New | $0 | |
| 2025-03-18 | 2025-03-14 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $121.18 | +1,819 | 7,550 | +32% | +$220.4K | |
| 2024-03-19 | 2024-03-15 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $147.48 | +1,678 | 5,711 | +42% | +$247.5K | |
| 2024-02-29 | 2024-02-28 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $27.04 | -21.4K | 321.7K | -6% | -$579.7K | |
| 2024-02-27 | 2024-02-23 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $27.76 | -24.8K | 343.2K | -7% | -$689.1K | |
| 2023-03-20 | 2023-03-16 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $136.82 | +1,658 | 4,018 | +70% | +$226.8K | |
| 2023-02-28 | 2023-02-25 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $41.75 | -37.1K | 354.1K | -9% | -$1.55M | |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $42.38 | -32.6K | 391.2K | -8% | -$1.38M |
| DM | 2022-11-09 | 2022-11-07 | PFE | Pfizer | Dolsten Mikael | Pres R, D | M - OptEx | $33.21 | +79.1K | 391.8K | +25% | +$2.63M |
| DM | 2022-05-12 | 2022-05-11 | PFE | Pfizer | Dolsten Mikael | Pres R, D | S - Sale | $49.32 | -63.9K | 333.3K | -16% | -$3.15M |
| 2022-03-21 | 2022-03-17 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $136.82 | +1,785 | 2,352 | +315% | +$244.2K | |
| DM | 2022-03-04 | 2022-03-03 | PFE | Pfizer | Dolsten Mikael | Pres R, D | M - OptEx | $31.83 | +102.5K | 396.6K | +35% | +$3.26M |
| 2022-03-01 | 2022-02-26 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $47.72 | -29.7K | 294.1K | -9% | -$1.42M | |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | Dolsten Mikael | Pres R, D | F - Tax | $46.87 | -29.8K | 323.9K | -8% | -$1.40M |
| D | 2021-12-21 | 2021-12-17 | PFE | Pfizer | Dolsten Mikael | Pres R, D | M - OptEx | $30.17 | +71.2K | 351.6K | +25% | +$2.15M |
| DM | 2021-11-15 | 2021-11-11 | PFE | Pfizer | Dolsten Mikael | Pres R, D | S - Sale+OE | $50.29 | -59.7K | 335.1K | -15% | -$3.00M |
| DM | 2021-11-15 | 2021-11-11 | PFE | Pfizer | Dolsten Mikael | Pres R, D | M - OptEx | $25.13 | +199.5K | 339.5K | +143% | +$5.01M |
| 2021-09-23 | 2021-09-22 | A | Agilent Technologies | Dolsten Mikael | Dir | A - Grant | $172.44 | +567 | 567 | New | +$97.8K |
Purchase Sale Sale after option exercise All abbreviations